Editors-in-Chief
|
James Henderson Naismith, Ph.D., Rosalind Franklin Institute, the University of Oxford, Oxford, UK
Prof. Naismith obtained his B.S. and Ph.D. degrees from University of Edinburgh and University of Manchester (UK), respectively. After finishing his postdoctoral training at the University of Texas Southwestern Medical Center (USA), Dr. Naismith became a faculty member at University of St Andrews (UK). Currently, Dr. Naismith is the professor and Director of the Research Complex at Harwell, and the director of Rosalind Franklin Institute, University of Oxford. He has published nearly 300 papers on international journals including Nature, Nature Structural & Molecular Biology, Nature Communications, Nucleic Acids Research and PNAS. Renowned for his investigations of protein structure by X-ray crystallography and targeted therapy by small molecules, Dr. Naismith is elected as a fellow of the Royal Society (UK), the Academy of Medical Sciences (UK), the Royal Society of Edinburgh, the Royal Society of Chemistry and the Royal Society of Biology (UK).
|
|
Günter P. Wagner, Ph.D., Yale Systems Biology Institute and Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, New Haven, USA
Günter P. Wagner is a pioneer of the field of evolutionary developmental biology. His research interest is the evolution of gene regulation, evolutionary medicine, and reproductive sciences. Prof. Wagner spent many years at the Max Planck Institutes for Biophysical Chemistry and Developmental Biology (Germany), and Department of Zoology, U. Vienna (Austria). Currently, he is the Alison Richard Professor emeritus of Ecology and Evolutionary Biology at Yale University, Research Professor at the Yale Systems Biology Institute and adjunct professor at the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. Prof. Wagner has published around 300 academic papers, including Nature, Nature Genetics, Genome Research, Nature Reviews Genetics, NEJM, PNAS, Science Advances and so on. Prof. Wagner received the MacArthur Fellowship and he was elected Corresponding Member of the Austrian Academy of Sciences, Fellow of the American Association for the Advancement of Science, the American Academy of Arts and Sciences, the Connecticut Academy of Science and Engineering and the US National Academy of Sciences.
|
|
Yu-quan Wei, Ph.D., State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, Sichuan University, Chengdu, China
Yu-quan Wei, Ph.D., Professor and Director of National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu. He was educated at West China University of Medical Sciences for a bachelor's degree in Medicine and a Master's Degree in Medicine, and educated at Kyoto University in Japan for a Doctoral Degree. His major research interests include targeted therapy, signal transduction, gene and cell therapy, and cancer vaccines. He has published more than 300 papers in international journals including Nat Med, Nat Commun, PNAS, Blood, Cancer Res, Clinic Cancer Res, J Immunol, and J Biol Chem, etc. He was selected as an academician of Chinese Academy of Sciences in 2003. He is now President of China Medicinal Biotech Association. He has served as an associate editor of Human Gene Therapy and Editorial Board Member of several International Journals.
|
Associate Editors
Max S. Cynader, Ph.D., University of British Columbia, Vancouver, Canada
Mohan Edirisinghe, Ph.D., University College London, London, UK
Guangping Gao, Ph.D., University of Massachusetts Medical School, Worcester, MA, USA
J. Silvio Gutkind, Ph.D., University of California, San Diego, CA, USA
Canhua Huang, Ph.D., State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
Peter E Huber, M.D., Ph.D., German Cancer Research Center, Heidelberg, Germany
Edouard Collins Nice, Ph.D., Monash University, Clayton, Victoria, Australia
Yong Peng, Ph.D., State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
Shazib Pervaiz, Ph.D., National University of Singapore, Singapore
Akihide Ryo, M.D., Ph.D., Yokohama City University School of Medicine, Yokohama-shi, Japan
Giannino Del Sal, Ph.D., University of Trieste, Trieste, Italy
Michael Y Sherman, Ph.D., Ariel University, Ariel, Israel
Koichi Tanaka, Ph.D., Department of Transplantation and Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Henning Ulrich, Ph.D., Universidade de São Paulo, São Paulo, Brazil
Francesco Di Virgilio, M.D., University of Ferrara, Ferrara, Italy
Kang Zhang, M.D., Ph.D., Macau University of Science and Technology, Macau, China
Song Guo Zheng, Shanghai Jiao Tong University, Shanghai, China
Editorial Board Members
Svetlana Antonyuk, Ph.D., University of Liverpool, Liverpool, UK
Rami I. Aqeilan, Ph.D., Hebrew University-Hadassa Medical Center, Jerusalem, Israel
Horacio Cabral, Ph.D., University of Tokyo, Tokyo, Japan
George A. Calin, M.D., Ph.D., MD Anderson Cancer Center, University of Texas, Houston, TX, USA
Zhe-sheng (Jason) Chen, M.D., Ph.D., St. John’s University, Queens, NY, USA
Arnold J.M. Driessen, Ph.D., University of Groningen, Groningen, Netherlands
Dongsheng Duan, Ph.D., University of Missouri, Columbia, MO, USA
Masanori Fukushima, M.D., Ph.D., Translational Research Center for Medical Innovation, Kobe, Japan
Ming-Liang He, Ph.D., City University of Hong Kong, Hong Kong, China
Timothy Hla, Ph.D., Harvard Medical School, Boston Children's Hospital, Harvard University, Boston, MA, USA
Zhen Huang, Ph.D., Georgia State University, Atlanta, GA, USA
Peter Illes, Ph.D., University of Leipzig, Leipzig, Germany
Lars Ittner, M.D., Dementia Research Centre, Macquarie University, Sydney, Australia
Shuo Lin, Ph.D., University of California, Los Angeles, CA, USA
Yih-Cherng Liou, Ph.D., National University of Singapore, Singapore
Qing Richard Lu, Ph.D., Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Pralay Maiti, Ph.D., Indian Institute of Technology, Banaras Hindu University, Varanasi, UP, India
Chitta Ranjan Patra, Ph.D., CSIR-Indian Institute of Chemical Technology, Hyderabad, India
Charles A. Powell, M.D., Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Zhiyong Qian, Ph.D., State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
Matthew Sachs, Ph.D., Texas A&M University, College Station, TX, USA
Alexey V. Semyanov, Ph.D., Russian Academy of Sciences, Moscow, Russia
Tsukasa Seya, M.D., Ph.D., Aomori University, Aomori, Japan
Hong-bing Shu, Ph.D., Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China
Weihong Song, M.D., Ph.D., The University of British Columbia, Vancouver, Canada
Vinay Tergaonkar, Ph.D., National University of Singapore, Singapore
Rajender Varma, Ph.D., US EPA, Cincinnati, Ohio, USA
Alexei Verkhratsky, M.D., Ph.D., The University of Manchester, Manchester, UK
Rong Xiang, M.D., Nankai University, Tianjin, China
Eitan Yefenof, Ph.D., Hebrew University, Jerusalem, Israel
Editorial Staff
|
Cherish Lee, Senior Editor
Cherish Lee received her B.A. degree from Southwest University and Ph.D. degree from University of Chinese Academy of Sciences. Before joining MedComm, she worked in Sichuan University. At present, she is the Senior Editor of MedComm.
|
Publishing Assistant
|
Mingsong Liu, John Wiley & Sons, Inc.
Mingsong Liu received his B.A. (Hons) from Queen's University in Kingston, Ontario, Canada, with major in Linguistics. He worked as a copywriting intern in Vancouver, Canada, and after graduation he joined Wiley as a Journal Publishing Assistant. At present, he is supporting Journal Publishing Managers in the Health Sciences team and its journal portfolio.
|
Pubdate: 2024-07-09
Viewed:
25